Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Nyxoah Expects Q2 2025 Revenue Growth Of 73% To ~€1.3M Following FDA Approval Of Genio System For Select OSA Patients

Author: Benzinga Newsdesk | August 11, 2025 02:56am

Posted In: NYXH